Overall MRNA gets a technical rating of 1 out of 10. MRNA scores bad on all fronts: it is a bad performer in the overall market and both the medium and short term pictures are negative.
The short term trend is neutral, while the long term trend is still negative. We need to see a little more continued positive action to make this really interesting.
96% of all other stocks performed better in the past year than MRNA.
MRNA is one of the lesser performing stocks in the Biotechnology industry. 73% of 561 stocks in the same industry do better.
MRNA is currently trading near the lower end of its 52 week range, which is not a good sign. The S&P500 Index is trading in the upper part of its 52 week range, so MRNA is lagging the market.
In the last month MRNA has a been trading in the 23.16 - 30.30 range, which is quite wide. It is currently trading near the high of this range.
Volume is considerably higher in the last couple of days, which is what you like to see during a strong movement up.
MRNA has an average volume of 10286200 traded shares per day. This is a good sign as it is always nice to have a liquid stock.
Prices have been rising strongly lately, it may be a good idea to wait for a consolidation or pullback before considering an entry.